Biblio
Export 1081 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is T [Clear All Filters]
“Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.”, J Alzheimers Dis, vol. 55, no. 2, pp. 539-549, 2017.
, “The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1659-1666, 2017.
, “Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.”, J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
, “Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.”, J Alzheimers Dis, vol. 70, no. 1, pp. 35-49, 2019.
, “A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1347-1360, 2018.
, “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
, “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
, “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
, “Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1243-1256, 2021.
, “Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”, J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
, “Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”, J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
, “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
, “Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 87-97, 2017.
, “Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1115-1130, 2022.
, “Cognitive Function in Individuals with Normal Weight Obesity: Results from the Third National Health and Nutrition Examination Survey (NHANES III).”, J Alzheimers Dis, vol. 65, no. 1, pp. 125-135, 2018.
, “Cognitive, Functional, and Emotional Changes During the COVID-19 Pandemic in Greek Patients with Neurocognitive Disorders.”, J Alzheimers Dis, vol. 88, no. 2, pp. 537-547, 2022.
, “Cognitive, Functional, and Emotional Changes During the COVID-19 Pandemic in Greek Patients with Neurocognitive Disorders.”, J Alzheimers Dis, vol. 88, no. 2, pp. 537-547, 2022.
, “Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.”, J Alzheimers Dis, 2024.
, “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
, “Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1315-1324, 2017.
, “Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.”, J Alzheimers Dis, vol. 52, no. 2, pp. 519-28, 2016.
, “Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 115-135, 2017.
, “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
,